Kiromic Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Kiromic Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10957
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Kiromic Inc (Kiromic) is a biotechnology company focused on developing immuno-oncology therapies. Its pipeline products include BSK01, an injectable drug that harness dendritic cells for the treatment of solid and hematological malignancies; BSK02, a synthetic oral cancer immunotherapy compound used to treat solid tumors. The company utilizes artificial intelligence disease-specific antigen discovery platform (KAI-BLADE), and drug development programs across multiple technology platforms including cellular therapies, TCR therapy, and CAR-T therapy, oral immunotherapy, and gene therapy. Kiromic’s Oral Delivery Platform (ODP) consists of synthetic and biocompatible microparticles that include cancer-specific immunotargets, immuno-stimulatory compounds, and lymphatic system targeting moieties that enhance the immunogenic response against cancer cells. The company works in collaboration with other research universities and advisory companies in the US. Kiromic is headquartered in Houston, Texas, the US.

Kiromic Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Kiromic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kiromic Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Kiromic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kiromic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Kiromic Inc, Medical Devices Deals, 2012 to YTD 2018 9
Kiromic Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Kiromic Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Kiromic Raises USD0.1 Million in Venture Financing 11
Partnerships 12
Kiromic Enters into Agreement with Oslo University Hospital Aker 12
Kiromic Enters into Agreement with University of Southern California 13
Kiromic Enters into Agreement with University of Texas MD Anderson Cancer Center 14
Kiromic Enters into Agreement with Bellicum Pharma 15
Kiromic Enters into Agreement with University of Texas MD Anderson Cancer Center 16
Kiromic Enters into Agreement with Harvard Medical School 17
Kiromic Enters into Agreement with Mercer University 18
Kiromic Inc – Key Competitors 19
Kiromic Inc – Key Employees 20
Kiromic Inc – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Corporate Communications 22
Oct 16, 2017: Peter Hoang Joins Kiromic Biopharma Board Of Directors 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Kiromic Inc, Pharmaceuticals & Healthcare, Key Facts 2
Kiromic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kiromic Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Kiromic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kiromic Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Kiromic Inc, Medical Devices Deals, 2012 to YTD 2018 9
Kiromic Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Kiromic Raises USD0.1 Million in Venture Financing 11
Kiromic Enters into Agreement with Oslo University Hospital Aker 12
Kiromic Enters into Agreement with University of Southern California 13
Kiromic Enters into Agreement with University of Texas MD Anderson Cancer Center 14
Kiromic Enters into Agreement with Bellicum Pharma 15
Kiromic Enters into Agreement with University of Texas MD Anderson Cancer Center 16
Kiromic Enters into Agreement with Harvard Medical School 17
Kiromic Enters into Agreement with Mercer University 18
Kiromic Inc, Key Competitors 19
Kiromic Inc, Key Employees 20

List of Figures
Kiromic Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Kiromic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Kiromic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Kiromic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Kiromic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kiromic Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Kiromic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kiromic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Kiromic Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Kiromic Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sega Sammy Holdings Inc (6460):企業の財務・戦略的SWOT分析
    Sega Sammy Holdings Inc (6460) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Rio Tinto:戦略・SWOT・企業財務分析
    Rio Tinto - Strategy, SWOT and Corporate Finance Report Summary Rio Tinto - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Environmental Container Systems Inc:企業の戦略・SWOT・財務情報
    Environmental Container Systems Inc - Strategy, SWOT and Corporate Finance Report Summary Environmental Container Systems Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Independent News & Media PLC (IPDC):企業の財務・戦略的SWOT分析
    Independent News & Media PLC (IPDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Green Cross Cell Corp (031390):企業の財務・戦略的SWOT分析
    Green Cross Cell Corp (031390) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • OncoTherapy Science Inc (4564):製薬・医療:M&Aディール及び事業提携情報
    Summary OncoTherapy Science Inc (OncoTherapy) is a biotechnology company that discovers and develops antibody drugs for treating cancer. The company offers products under antibodies, cancer vaccines and small molecule drugs. It provides contract research services. OncoTherapy conducts research and d …
  • Dayton Superior Corporation:企業の戦略的SWOT分析
    Dayton Superior Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Electromed Inc (ELMD):企業の財務・戦略的SWOT分析
    Summary Electromed Inc (Electromed) is a medical device company that designs, manufactures and markets respiratory care products using airway clearance technologies. The company provides smartvest airway clearance system used through in-home and in-patient therapies for respiratory treatments. It of …
  • Xenon Pharmaceuticals Inc (XENE):企業の財務・戦略的SWOT分析
    Summary Xenon Pharmaceuticals Inc (Xenon), formerly Xenon Genetics Inc, is a biopharmaceutical company that develops medicines to treat neurological disorders. The company is investigating XEN1101, a Kv7 potassium channel modulator against epilepsy; XEN496 for the treatment of seizures associated wi …
  • Puncak Niaga Holdings Bhd (PUNCAK):企業の財務・戦略的SWOT分析
    Puncak Niaga Holdings Bhd (PUNCAK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Good Energy Group PLC (GOOD):電力:M&Aディール及び事業提携情報
    Summary Good Energy Group PLC (Good Energy) is a vertically integrated energy utility. It supplies renewable electricity and gas; provides feed in tariff services; and procures electricity from renewable energy generators. The company serves as an integrator of green energy and technical services. G …
  • Praxair, Inc.:企業のM&A・事業提携・投資動向
    Praxair, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Praxair, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Ck Hutchison Holdings Ltd:企業の戦略・SWOT・財務分析
    Ck Hutchison Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Ck Hutchison Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • STR Holdings, Inc.:企業の戦略的SWOT分析
    STR Holdings, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • CWC Energy Services Corp (CWC):石油・ガス:M&Aディール及び事業提携情報
    Summary CWC Energy Services Corp (CWC), formerly CWC Well Services Corp, is an oilfield servicing company that provides drilling rigs, service rigs, coil tubing and well testing services in the Western Canadian Sedimentary Basin. The company operates through two divisions such as contract drilling a …
  • Waste Management, Inc.:企業の戦略・SWOT・財務分析
    Waste Management, Inc. - Strategy, SWOT and Corporate Finance Report Summary Waste Management, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • PeptiDream Inc (4587):企業の財務・戦略的SWOT分析
    Summary PeptiDream Inc (PeptiDream) operates as a biopharmaceutical company. It discovers and develops peptides, peptide-drug, small molecule based, and conjugate therapeutics to address unmet medical needs. The company provides a proprietary peptide discovery platform system (PDPS), a versatile dis …
  • Jupiter Energy Ltd (JPR):石油・ガス:M&Aディール及び事業提携情報
    Summary Jupiter Energy Ltd (Jupiter Energy) is an oil exploration and production company that carries out acquisition, exploration, production, and develops oil and natural gas properties. The company holds an exploration permit in the oil-rich Mangistau Basin in West Kazakhstan. It also holds inter …
  • Aeolus Pharmaceuticals Inc (AOLS)-製薬・医療分野:企業M&A・提携分析
    Summary Aeolus Pharmaceuticals Inc (Aeolus) is a biopharmaceutical company that is developing a platform of new compounds for use in cancer, infectious diseases, central nervous system (CNS) diseases, fibrosis and biodefense. The company’s lead product, AEOL 10150 is a broad catalytic antioxidant pa …
  • Aitken Spence Hotel Holdings PLC:企業の戦略・SWOT・財務情報
    Aitken Spence Hotel Holdings PLC - Strategy, SWOT and Corporate Finance Report Summary Aitken Spence Hotel Holdings PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆